![]() |
市場調查報告書
商品編碼
1496764
大麻市場:按形式、產品類型、化合物、來源、分銷管道、應用 - 2024-2030 年全球預測Cannabis Market by Form (Concentrated Oil, Cream, Food Additive), Product Type (Concentrates, Flower, leaves), Compound, Source, Distribution Channel, Application - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年大麻市場規模為327.3億美元,預計2024年將達417.7億美元,2030年將達到1872.4億美元,複合年成長率為28.29%。
源自大麻的大麻市場產品包括但不限於乾燥花、濃縮物、食用品、外用藥和大麻素,例如 THC(四氫大麻酚)和 CBD(大麻二酚)。大麻產業服務於各種最終用途領域,包括醫療、製藥、個人護理以及食品和飲料。在醫療領域,大麻用於緩解與慢性疼痛、癌症、癲癇、多發性硬化症等相關的症狀。大麻的休閒用途提供了酒精和菸草等傳統休閒產品的替代品。大麻市場範圍包括全球和區域銷售、產品創新、供應鏈管理、監管狀況等。大麻市場成長的主要驅動力是日益合法化、擴大藥用用途以及擴大採用大麻作為消費品。此外,遺傳學和種植技術的進步以及大麻相關調查投資的增加也有助於市場擴張。大麻市場的最新潛在機會包括快速成長的 CBD 市場,特別是在健康和保健領域,整合區塊鏈以提高供應鏈透明度,以及探索新的輸送系統以提高生物有效性。飲料和偏好產品等大麻產品以及根據個人基因特徵量身定做的個人化大麻藥物領域的創新尤其活躍。此外,為了吸引具有環保意識的消費者,我們將引入環保的種植和加工方法,克服恥辱,並投資於消費者教育以告知負責任的使用。利用人工智慧和機器學習對種植和消費者偏好進行預測分析預計將推動市場成長。然而,不同司法管轄區存在複雜的監管障礙、高昂的合規成本以及大麻使用持續存在的污名化。此外,劑量和攝取方法缺乏標準化、黑市經營者的激烈競爭以及銀行和金融服務的高障礙限制了市場潛力。
主要市場統計 | |
---|---|
基準年[2023] | 327.3億美元 |
預測年份 [2024] | 417.7億美元 |
預測年份 [2030] | 1872.4億美元 |
複合年成長率(%) | 28.29% |
區域洞察
美洲是一個複雜且快速擴張的大麻市場,各州之間的法律體制存在細微差異,聯邦層級幾乎沒有變化。消費者的需求因地區和人口而異,趨勢顯示對藥用大麻產品和合法州休閒大麻產品的需求顯著增加。顧客的購買行為顯示出對偏好和電子煙的強烈趨勢。雖然新專利的競爭加劇,特別是在種植技術和大麻素合成方面,但一些州已經開始了調查計畫。在亞太地區,中國和印度涉足大麻市場主要集中於生產大麻,這是一種非精神活性品種。中國是大麻衍生產品(包括紡織品和大麻二酚(CBD)萃取物)的最大生產國之一,但國內消費受到嚴格監管。另一方面,印度是一個有著古老文化聯繫的新興市場,但仍受到嚴格監管,並顯示出在醫學研究和阿育吠陀方面的應用潛力。在歐洲,大麻的監管環境分散,德國、義大利和荷蘭等國家在患者准入和產品多樣性方面處於領先地位,並且總體上正在走向更加開放的醫藥市場。歐盟客戶的購買行為反映出人們對大麻潛在醫療益處的認知和接受程度不斷提高,從而導致對藥用大麻產品和相關研究的投資增加。
FPNV定位矩陣
FPNV 定位矩陣對於評估供應商在大麻市場的定位至關重要。此矩陣提供了對供應商的全面評估,並檢查與業務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估結果,供應商被分為代表其成功程度的四個像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對大麻市場供應商的現狀進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻,您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他重要指標。此外,該分析也為此細分市場的競爭性質提供了寶貴的見解,包括研究的累積時間、片段化主導地位和合併特徵等因素。有了這些詳細資訊,供應商可以做出更明智的決策並製定有效的策略,以在市場競爭中保持領先地位。
策略分析與建議
策略分析對於尋求在全球市場站穩腳跟的組織至關重要。透過徹底評估其當前在大麻市場的地位,公司可以做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析,以確定核心優勢和需要改進的領域。
[187 Pages Report] The Cannabis Market size was estimated at USD 32.73 billion in 2023 and expected to reach USD 41.77 billion in 2024, at a CAGR 28.29% to reach USD 187.24 billion by 2030.
The cannabis market products derived from cannabis include but are not limited to dry flowers, concentrates, edibles, topicals, and cannabinoids such as THC (tetrahydrocannabinol) and CBD (cannabidiol). The cannabis industry serves various end-use sectors, such as healthcare, pharmaceuticals, personal care, and food & beverages. In the medical sector, cannabis is prescribed to alleviate symptoms associated with chronic pain, cancer, epilepsy, and multiple sclerosis, among others. The recreational use of cannabis provides an alternative to traditional leisure substances such as alcohol and tobacco. The scope of the cannabis market includes global and regional sales, product innovation, supply chain management, and regulatory landscapes. Cannabis market growth is predominantly driven by increasing legalization, growing medicinal applications, and the rising adoption of cannabis as a consumer good. Furthermore, advancements in genetics and cultivation technology, and increasing investment in cannabis-related research, contribute to the market's expansion. The latest potential opportunities within the cannabis market include the burgeoning CBD market, especially in the health and wellness sector, the integration of blockchain for supply chain transparency, and the exploration of new delivery systems to enhance bioavailability. Innovations are particularly thriving in areas of cannabis-infused products, such as beverages and edibles, as well as personalized cannabis medicines tailored to individual genetic profiles. Furthermore, implementing eco-friendly cultivation and processing methods to appeal to environmentally-conscious consumers and investing in consumer education to overcome stigma and inform about responsible use. Leveraging AI and machine learning for predictive analytics in cultivation and consumer preferences is expected to propel market growth. However, complex regulatory hurdles across different jurisdictions, high compliance costs, and the persistent stigmatization of cannabis use. In addition, the lack of standardized dosing and methods of consumption, significant competition from black-market operators, and hurdles in banking and financial services pose limitations to the market's potential.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 32.73 billion |
Estimated Year [2024] | USD 41.77 billion |
Forecast Year [2030] | USD 187.24 billion |
CAGR (%) | 28.29% |
Regional Insights
The Americas represents a complex and rapidly expanding cannabis market, differing minimally at the federal level but with nuanced legal frameworks across the states. Consumer needs vary significantly by region and demographics, with trends showing a substantial increase in demand for both medicinal and, in legal states, recreational cannabis products. Customer purchasing behavior demonstrates a strong inclination towards edibles and vapes. Several states have initiated research programs while the race for new patents is intense, particularly in cultivation tech and cannabinoid synthesis. In APAC, China's and India's involvement in the cannabis market is predominantly focused on the production of hemp, a non-psychoactive variety of cannabis. China is one of the largest producers of hemp-derived products such as textiles and cannabidiol (CBD) extracts, though consumption within the country remains strictly controlled. Meanwhile, India presents a nascent market with ancient cultural ties to cannabis, and while still heavily regulated, it shows potential for medical cannabis research and Ayurvedic applications. In Europe, the regulatory landscape for cannabis is fragmented but generally moving towards more open medicinal markets, with countries such as Germany, Italy, and the Netherlands leading in patient access and product diversity. The EU's customer purchasing behavior reflects a growing awareness and acceptance of the potential medical benefits of cannabis, leading to increased investment in pharmaceutical cannabis products and related research.
Market Insights
The market dynamics represent an ever-changing landscape of the Cannabis Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Cannabis Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Cannabis Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Organigram Announces USD 92.91 Million Investment from BAT and Creation of "Jupiter" Strategic Investment Pool
Organigram Holdings Inc. announced a significant USD 92.91 million equity investment from BT DE Investments Inc., a subsidiary of British American Tobacco. This strategic infusion of capital represents a powerful endorsement from a leading consumer goods company and is poised to fast-track Organigram's growth trajectory. With the investment, named "Jupiter," Organigram aims to expand its reach, enhance its technological capabilities, and diversify its product offerings. The initiative further cements the already robust partnership with BAT, tapping into their expansive global resources and scientific prowess for shared progressive ventures. [Published On: 2023-11-06]
Tilray Closes Acquisition of Hexo Corp To Create 'Largest Canadian Cannabis Company by Revenue'
Tilray, Inc. has effectively concluded its acquisition of Hexo Corp, solidifying its position as the preeminent Canadian cannabis company based on revenue. This strategic move bolsters the firm's competitiveness against Canopy Growth Corporation, positioning it for market leadership. Additionally, the integration is set to drive significant operational efficiencies, with anticipated annual cost savings of USD 27 million. In the mechanics of the deal, Tilray issued approximately 19.5 million common shares, granting former Hexo shareholders 0.4352 of a Tilray share for each Hexo share held, leading to the cessation of Hexo's stock trading. [Published On: 2023-06-26]
Curaleaf Completes Acquisition of Deseret Wellness
Curaleaf Holdings, Inc. has successfully finalized its acquisition of Deseret Wellness, Utah's foremost cannabis retailer. This strategic move significantly bolsters Curaleaf's presence in the burgeoning Utah market, expanding their local dispensary count to four and extending the company's reach to an impressive 150 retail locations throughout the United States. The integration of Deseret Wellness under the Curaleaf banner marks yet another milestone in the company's expansion, highlighting its commitment to growth and leadership in the nation's competitive cannabis industry. [Published On: 2023-04-10]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Cannabis Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Cannabis Market, highlighting leading vendors and their innovative profiles. These include Acreage Holdings, Aphria, Inc., Aurora Cannabis Inc., Cannabis Science Inc., Canopy Growth Corporation, Chronos Group Inc., Cresco Labs, Inc., Curaleaf Holdings, Inc., CV Sciences Inc., EcoGen Biosciences, Elixinol Wellness Limited, Extractas Bioscience, Folium Europe B.V., Green Thumb Industries Inc., Lexaria Bioscience Corp., Medical Marijuana, Inc., MediPharm Labs Inc., Organigram Holdings Inc., Peace Naturals Project Inc., PharmaHemp d.o.o., StenoCare A/S, The Seed Cellar, and Tikun Olam.
Market Segmentation & Coverage
TABLE 3